Dr. Dermot Pearson

Strategic Marketing Director Novozymes Biopharma UK Ltd.

Dermot Pearson has over 25 years working in the biotech industry in a range of technical and commercial roles. Currently Strategic Marketing Director Drug Delivery & Formulation and business unit management team member at Novozymes Biopharma UK. He has formerly held roles in Commercial Operations, Manufacturing Operations, Quality Control and Process Development at Delta Biotechnology Ltd, (owned by Sanofi, and subsequently by Novozymes), and is currently responsible for all market development aspects of one of company's two lead products. Role includes brand development and management, product segment extension, key contracts negotiation, product positioning and pricing, all on global basis. In previous roles he has also been responsible for sales, and business development for company's products and technologies, as well as Regulatory Affairs, reporting to CEO. Previously Manufacturing Director for a biopharmaceutical facility operating to FDA and EU cGMP standards. Extensive experience of cGMP operating environment manufacturing product for clinical and commercial supply, specifically dealing with bulk manufacture, contract filler oversight, operational efficiency improvement programme oversight. While Head of QC managed laboratory equipment and methods validation, and general cGMP compliance programmes. Major input to writing CMC section of IND & product master files and have made CMC presentations to FDA and EMA.


Chinese (Traditional)EnglishJapanese